Eph receptors: New players in Alzheimer's disease pathogenesis
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is devastating and leads to permanent losses of memory and other cognitive functions. Although recent genetic evidences strongly argue for a causative role of Aβ in AD onset and progression (Jonsson et al., 2012), its role in AD etiology remains a matter of debate. However, even if not the sole culprit or pathological trigger, genetic and anatomical evidences in conjunction with numerous pharmacological studies, suggest that Aβ peptides, at least contribute to the disease. How Aβ contributes to memory loss remains largely unknown. Soluble Aβ species referred to as Aβ oligomers have been shown to be neurotoxic and induce network failure and cognitive deficits in animal models of the disease. In recent years, several proteins were described as potential Aβ oligomers receptors, amongst which are the receptor tyrosine kinases of Eph family. These receptors together with their natural ligands referred to as ephrins have been involved in a plethora of physiological and pathological processes, including embryonic neurogenesis, learning and memory, diabetes, cancers and anxiety. Here we review recent discoveries on Eph receptors-mediated protection against Aβ oligomers neurotoxicity as well as their potential as therapeutic targets in AD pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 1×
“The load of oligomeric Aβ in the brain is apparently more intimately correlated with cellular and cognitive dysfunction rather than fibrils and plaques (Lambert et al., 1998; Mucke et al., 2000; Walsh and Selkoe, 2004; Glabe, 2006; Lesne et al., 2006).”
BackgroundRetractedAβ Oligomers – a decade of discovery
Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856 · cited 1×
“The load of oligomeric Aβ in the brain is apparently more intimately correlated with cellular and cognitive dysfunction rather than fibrils and plaques (Lambert et al., 1998; Mucke et al., 2000; Walsh and Selkoe, 2004; Glabe, 2006; Lesne et al., 2006).”
BackgroundTwenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective
Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849
A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
Jonsson, T., Atwal, J. K., Steinberg, S., Snaedal, J., Jonsson, P. V., Bjornsson, S., Stefansson, H., Sulem, P., Gudbjartsson, D., Maloney, J., et al. (2012) · Nature · doi:10.1038/nature11283 · Cited by 1,738
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
Hardingham, G. E., & Bading, H. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2911 · Cited by 1,644 · cited 2×
“An emerging concept is that an imbalance between extrasynaptic and synaptic NMDAR activity might be central to synaptic dysfunction and cognitive deficits in neurodegenerative diseases (Lau and Zukin, 2007; Hardingham and Bading, 2010).”
BackgroundAPP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644 · cited 1×
“NMDARs play an important role in synaptic plasticity (Kamenetz et al., 2003;Walsh and Selkoe, 2004; Shankar et al., 2007, 2008).”
Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592 · cited 1×
“NMDARs play an important role in synaptic plasticity (Kamenetz et al., 2003;Walsh and Selkoe, 2004; Shankar et al., 2007, 2008).”
BackgroundIncreasing adult hippocampal neurogenesis is sufficient to improve pattern separation
Sahay, A., Scobie, K. N., Hill, A. S., O'Carroll, C. M., Kheirbek, M. A., Burghardt, N. S., Fenton, A. A., Dranovsky, A., & Hen, R. (2011) · Nature · doi:10.1038/nature09817 · Cited by 1,567 · cited 1×
“More recently, a genetic expansion of the population of adult-born neurons in the hippocampus through an enhancement of their survival was sufficient to improve performance in a specific cognitive task in mice (Sahay et al., 2011).”
BackgroundRegulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561 · cited 1×
“For instance, Aβ reduced NMDAR subunit NR1 in neuronal cell culture and in hAPP transgenic mice via the activation of α-7 nicotinic receptor and the tyrosine phosphatase STEP (Striatal-enriched protein tyrosine phosphatase) (Snyder et al., 2005).”
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
Laurén, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., & Strittmatter, S. M. (2009) · Nature · doi:10.1038/nature07761 · Cited by 1,560
Deciphering the Molecular Basis of Memory Failure in Alzheimer's Disease
Walsh, D. M., & Selkoe, D. J. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.010 · Cited by 1,207 · cited 2×
“The load of oligomeric Aβ in the brain is apparently more intimately correlated with cellular and cognitive dysfunction rather than fibrils and plaques (Lambert et al., 1998; Mucke et al., 2000; Walsh and Selkoe, 2004; Glabe, 2006; Lesne et al., 2006).”
BackgroundLacor, P. N., Buniel, M. C., Furlow, P. W., Sanz Clemente, A., Velasco, P. T., Wood, M., Viola, K. L., & Klein, W. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3501-06.2007 · Cited by 1,188 · cited 1×
“…et al., 2012; Kao et al., 2012; Mohamed et al., 2012; Xu and Henkemeyer, 2012; Luxey et al., 2013; Robichaux et al., 2014) Alzheimer's disease (Lacor et al., 2007; Simon et al., 2009; Ethell, 2010; Cisse et al., 2011; Malenka and Malinow, 2011; Wood, 2011; Barthet et al., 2013; Geng et al.,…”
BackgroundNMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders
Lau, C. G., & Zukin, R. S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2153 · Cited by 1,159 · cited 1×
“An emerging concept is that an imbalance between extrasynaptic and synaptic NMDAR activity might be central to synaptic dysfunction and cognitive deficits in neurodegenerative diseases (Lau and Zukin, 2007; Hardingham and Bading, 2010).”
BackgroundMolecular biology of amyotrophic lateral sclerosis: insights from genetics
Pasinelli, P., & Brown, R. H. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1971 · Cited by 1,107
AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss
Hsieh, H., Boehm, J., Sato, C., Iwatsubo, T., Tomita, T., Sisodia, S., & Malinow, R. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.035 · Cited by 1,042
Neurotoxicity of Amyloid -Protein: Synaptic and Network Dysfunction
Mucke, L., & Selkoe, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006338 · Cited by 1,000 · cited 2×
“Unfortunately many therapies had unintended adverse effects and none has shown dramatic effects in clinical trials (Mucke and Selkoe, 2012).”
BackgroundIncreased hippocampal neurogenesis in Alzheimer's disease
Jin, K., Peel, A. L., Mao, X. O., Xie, L., Cottrell, B. A., Henshall, D. C., & Greenberg, D. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2634794100 · Cited by 971 · cited 16×
“Memantine significantly improved the acquisition of the water maze in APP/PS1 mice without affecting swimming speed, suggesting that it could be beneficial in hippocampal-dependent spatial learning tasks (Minkeviciene et al., 2004).”
BackgroundInfluentialKee, N., Teixeira, C. M., Wang, A. H., & Frankland, P. W. (2007) · Nature Neuroscience · doi:10.1038/nn1847 · Cited by 875 · cited 2×
“…that defines the architecture and function of the hippocampus and highlights the complexity of a structure that plays an important role in learning and memory (Lennington et al., 2003; Song and Jiang, 2005; Tozuka et al., 2005; Ge et al., 2006; Overstreet-Wadiche et al., 2006; Kee et al., 2007).”
BackgroundBidirectional ephrinB2-EphB4 signaling controls bone homeostasis
Zhao, C., Irie, N., Takada, Y., Shimoda, K., Miyamoto, T., Nishiwaki, T., Suda, T., & Matsuo, K. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.012 · Cited by 777
Current hypotheses for the underlying biology of amyotrophic lateral sclerosis
Rothstein, J. D. (2009) · Annals of Neurology · doi:10.1002/ana.21543 · Cited by 703 · cited 2×
“…impaired trophic support, altered glial function, viral infection and immune imbalance (Bruijn et al., 2004; Consilvio et al., 2004; Strong et al., 2005; Pasinelli and Brown, 2006; Van den Bosch, 2006; Mitchell and Borasio, 2007; Mitchell et al., 2007; Rothstein, 2009; Saleh et al., 2009).”
BackgroundAmyloid beta oligomers induce impairment of neuronal insulin receptors
Zhao, W., De Felice, F. G., Fernandez, S., Chen, H., Lambert, M. P., Quon, M. J., Krafft, G. A., & Klein, W. L. (2008) · The FASEB Journal · doi:10.1096/fj.06-7703com · Cited by 587 · cited 2×
“, 2013), Insulin receptor (Zhao et al., 2008), EphB2 receptor (Cisse et al.”
BackgroundUm, J. W., Kaufman, A. C., Kostylev, M., Heiss, J. K., Stagi, M., Takahashi, H., Kerrisk, M. E., Vortmeyer, A., Wisniewski, T., Koleske, A. J., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.06.036 · Cited by 572
Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease
D'Amelio, M., Cavallucci, V., Middei, S., Marchetti, C., Pacioni, S., Ferri, A., Diamantini, A., De Zio, D., Carrara, P., Battistini, L., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2709 · Cited by 572 · cited 1×
“These molecular modifications altered glutamatergic synaptic transmission and plasticity and correlated with spine degeneration and a deficit in hippocampal-dependent memory (D'Amelio et al., 2011).”
BackgroundCommon mechanisms of amyloid oligomer pathogenesis in degenerative disease
Glabe, C. G. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.04.017 · Cited by 569 · cited 1×
“The load of oligomeric Aβ in the brain is apparently more intimately correlated with cellular and cognitive dysfunction rather than fibrils and plaques (Lambert et al., 1998; Mucke et al., 2000; Walsh and Selkoe, 2004; Glabe, 2006; Lesne et al., 2006).”
BackgroundAdvanced glycation endproducts and their receptor RAGE in Alzheimer's disease
Srikanth, V., Maczurek, A., Phan, T., Steele, M., Westcott, B., Juskiw, D., & Münch, G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.016 · Cited by 524 · cited 3×
“…cellular prion protein (Lauren et al., 2009), EphB2 (Renner et al., 2010; Cisse et al., 2011), RAGE (Receptor for Advanced Glycation Endproducts) (Srikanth et al., 2011), or NR2B-containing NMDARs (Ronicke et al., 2011), have all been described to directly or indirectly mediate Aβ oligomers…”
BackgroundReelin, lipoprotein receptors and synaptic plasticity
Herz, J., & Chen, Y. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn2009 · Cited by 524
Control of hippocampal dendritic spine morphology through ephrin-A3/EphA4 signaling
Murai, K. K., Nguyen, L. N., Irie, F., Yamaguchi, Y., & Pasquale, E. B. (2003) · Nature Neuroscience · doi:10.1038/nn994 · Cited by 516 · cited 2×
“…Kania, 2014; Steinecke et al., 2014) Atherosclerosis (Funk et al., 2012; Funk and Orr, 2013) t1:9 Hippocampus maturation (Henkemeyer et al., 2003; Murai et al., 2003; Martinez and Soriano, 2005; Otal et al., 2006; Rodenas-Ruano et al., 2006; Chumley et al., 2007; Akaneya et al., 2010; Margolis…”
BackgroundDeleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5
Renner, M., Lacor, P. N., Velasco, P. T., Xu, J., Contractor, A., Klein, W. L., & Triller, A. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.029 · Cited by 468 · cited 6×
“Thus, cellular prion protein (Lauren et al., 2009), EphB2 (Renner et al., 2010; Cisse et al., 2011), RAGE (Receptor for Advanced Glycation Endproducts) (Srikanth et al., 2011), or NR2B-containing NMDARs (Ronicke et al., 2011), have all been described to directly or indirectly mediate Aβ oligomers…”
BackgroundInfluentialPenzes, P., Beeser, A., Chernoff, J., Schiller, M. R., Eipper, B. A., Mains, R. E., & Huganir, R. L. (2003) · Neuron · doi:10.1016/s0896-6273(02)01168-6 · Cited by 466 · cited 3×
“, 2013) t1:7 Spines formation (Penzes et al., 2003; Kayser et al., 2006, 2008; Fu et al., 2007; Segura et al., 2007; Tolias et al., 2007; Tremblay et al., 2007; Chen and Fu, 2009; Klein, 2009; Lai and Ip, 2009; Shi et al., 2009; Akaneya et al., 2010; Cesa et al., 2011; Xu et al., 2011; Sloniowski and Ethell, 2012; Zho…”
BackgroundReversing EphB2 depletion rescues cognitive functions in Alzheimer model
Cissé, M., Halabisky, B., Harris, J., Devidze, N., Dubal, D. B., Sun, B., Orr, A., Lotz, G., Kim, D. H., Hamto, P., et al. (2011) · Nature · doi:10.1038/nature09635 · Cited by 433 · cited 20×
“Thus, cellular prion protein (Lauren et al., 2009), EphB2 (Renner et al., 2010; Cisse et al., 2011), RAGE (Receptor for Advanced Glycation Endproducts) (Srikanth et al., 2011), or NR2B-containing NMDARs (Ronicke et al., 2011), have all been described to directly or indirectly mediate Aβ oligomers…”
BackgroundInfluentialSelf-citationKim, T., Vidal, G. S., Djurisic, M., William, C. M., Birnbaum, M. E., Garcia, K. C., Hyman, B. T., & Shatz, C. J. (2013) · Science · doi:10.1126/science.1242077 · Cited by 410 · cited 3×
“, 2011), human LilrB2 (Kim et al., 2013) and more recently, Reelin (Pujadas et al.”
BackgroundActivity-dependent dynamics and sequestration of proteasomes in dendritic spines
Bingol, B., & Schuman, E. M. (2006) · Nature · doi:10.1038/nature04769 · Cited by 347 · cited 1×
“Indeed, proteasomes structure, trafficking and subcellular localization are tightly regulated by different cellular mechanisms including synaptic activity, stress, O-glycosylation, or phosphorylation (Glickman and Raveh, 2005; Bingol and Schuman, 2006; Bingol et al., 2010).”
BackgroundAutophosphorylated CaMKIIα Acts as a Scaffold to Recruit Proteasomes to Dendritic Spines
Bingol, B., Wang, C.-F., Arnott, D., Cheng, D., Peng, J., & Sheng, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.024 · Cited by 268
Seizures accelerate functional integration of adult-generated granule cells
Overstreet-Wadiche, L. S., Bromberg, D. A., Bensen, A. L., & Westbrook, G. L. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5508-05.2006 · Cited by 266 · cited 2×
“…that defines the architecture and function of the hippocampus and highlights the complexity of a structure that plays an important role in learning and memory (Lennington et al., 2003; Song and Jiang, 2005; Tozuka et al., 2005; Ge et al., 2006; Overstreet-Wadiche et al., 2006; Kee et al., 2007).”
BackgroundMargolis, S. S., Salogiannis, J., Lipton, D. M., Mandel-Brehm, C., Wills, Z. P., Mardinly, A. R., Hu, L., Greer, P. L., Bikoff, J. B., Ho, H.-Y. H., et al. (2010) · Cell · doi:10.1016/j.cell.2010.09.038 · Cited by 256 · cited 2×
“…2003; Murai et al., 2003; Martinez and Soriano, 2005; Otal et al., 2006; Rodenas-Ruano et al., 2006; Chumley et al., 2007; Akaneya et al., 2010; Margolis et al., 2010; Xu et al., 2011) Inflammation (Kitamura et al., 2008; Carpenter et al., 2012; Coulthard et al., 2012) t1:10 LTP formation (Gao…”
BackgroundArc regulates spine morphology and maintains network stability in vivo
Peebles, C. L., Yoo, J., Thwin, M. T., Palop, J. J., Noebels, J. L., & Finkbeiner, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006546107 · Cited by 245 · cited 1×
“Calcium entry through NMDARs is a key event that regulates synaptic plasticity via activation of transcription factors and immediate-early genes such as c-fos and Arc (Peebles et al., 2010; Korb and Finkbeiner, 2011; Korb et al., 2013).”
BackgroundPrion protein and Aβ‐related synaptic toxicity impairment
Calella, A. M., Farinelli, M., Nuvolone, M., Mirante, O., Moos, R., Falsig, J., Mansuy, I. M., & Aguzzi, A. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000082 · Cited by 242 · cited 2×
“A very elegant study demonstrated that the crossing of mice engineered to produce an anchorless PrP with βAPP transgenic mice effectively interfered and improved LTP-associated deficit in these animals, without affecting βAPP metabolism or Aβ levels (Calella et al., 2010).”
Sun, B., Halabisky, B., Zhou, Y., Palop, J. J., Yu, G., Mucke, L., & Gan, L. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.10.003 · Cited by 205
Fu, A. K. Y., Hung, K.-W., Huang, H., Gu, S., Shen, Y., Cheng, E. Y. L., Ip, F. C. F., Huang, X., Fu, W.-Y., & Ip, N. Y. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405803111 · Cited by 201 · cited 2×
“In a similar vein, an enhanced EphA4 signalingwas observed in the hippocampus of amyloid precursor protein (APP)/presenilin 1 (PS1) transgenic mouse model of AD (Fu et al., 2014).”
BackgroundChin, J., Massaro, C. M., Palop, J. J., Thwin, M. T., Yu, G.-Q., Bien-Ly, N., Bender, A., & Mucke, L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3758-06.2007 · Cited by 188
Pujadas, L., Rossi, D., Andrés, R., Teixeira, C. M., Serra-Vidal, B., Parcerisas, A., Maldonado, R., Giralt, E., Carulla, N., & Soriano, E. (2014) · Nature Communications · doi:10.1038/ncomms4443 · Cited by 129 · cited 12×
“, 2012), and overexpressing Reelin delayed amyloid plaque formation and rescued memory deficits in mice carrying the APPSwe/Ind mutation (J20 mice) (Pujadas et al., 2014).”
BackgroundInfluentialReelin depletion is an early phenomenon of Alzheimer's pathology
Herring, A., Donath, A., Steiner, K. M., Widera, M. P., Hamzehian, S., Kanakis, D., Kölble, K., ElAli, A., Hermann, D. M., Paulus, W., et al. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-112069 · Cited by 92 · cited 2×
“Furthermore, Reelin levels are reduced in hAPP transgenicmice and inAD (Chin et al., 2007;Herring et al., 2012), and overexpressing Reelin delayed amyloid plaque formation and rescued memory deficits in mice carrying the APPSwe/Ind mutation (J20 mice) (Pujadas et al., 2014).”
BackgroundKalirin is Under-Expressed in Alzheimer's Disease Hippocampus
Youn, H., Jeoung, M., Koo, Y., Ji, H., Markesbery, W. R., Ji, I., & Ji, T. H. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-11314 · Cited by 77
Calò, L., Cinque, C., Patanè, M., Schillaci, D., Battaglia, G., Melchiorri, D., Nicoletti, F., & Bruno, V. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03844.x · Cited by 55
Cited by
Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk
Walker, K. A., Chen, J., Zhang, J., Fornage, M., Yang, Y., Zhou, L., Grams, M. E., Tin, A., Daya, N., Hoogeveen, R. C., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00064-0 · Cited by 212
A neuroprotective astrocyte state is induced by neuronal signal EphB1 but fails in ALS models
Tyzack, G. E., Hall, C. E., Sibley, C. R., Cymes, T., Forostyak, S., Carlino, G., Meyer, I. F., Schiavo, G., Zhang, S.-C., Gibbons, G. M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01283-z · Cited by 128
The Role of Ephs and Ephrins in Memory Formation
Dines, M., & Lamprecht, R. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv106 · Cited by 47
Regulation of postsynaptic signaling in structural synaptic plasticity
Fu, A. K., & Ip, N. Y. (2017) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2017.05.016 · Cited by 43
Alzheimer’s disease genetics converges on microglial and neuronal dysregulation
Uffelmann, E., Wightman, D. P., Bahrami, S., Shadrin, A. A., Fominykh, V., Ojima, T., Jiang, C., Benner, C., Moreno, E., Campos, A. I., et al. (2026) · Nature · doi:10.1038/s41586-026-11206-y
Metadata
- Authors
- Cissé, M., & Checler, F.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 73
- Pages
- 137-149
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2015310474
- Cited by
- 46
- References
- 45
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.